New open-source software tool, known as GatorpH, helps expose hidden cavity risk
When the Food and Drug Administration issued a safety warning in 2022 about severe tooth decay associated with a commonly prescribed, orally dissolving opioid use disorder medication called buprenorphine, University of Florida researchers asked the question: How could scientists better measure the oral conditions that put teeth at risk?
In response to FDA safety concerns regarding buprenorphine, a medication prescribed for opioid use disorder, University of Florida researchers have developed GatorpH, an open-source software tool. This tool aims to uncover hidden cavity risks associated with the medication by accurately measuring dynamic changes in oral pH. Under the guidance of Dr. Abhisheak Sharma and Dr. Omar Elashkar, GatorpH takes into account biological factors like bacterial acid production and saliva buffering, providing a more accurate reconstruction of oral pH changes compared to traditional methods.
By eliminating the need for expensive, time-consuming continuous plaque pH monitoring, GatorpH offers a cost-effective solution for researchers studying the impact of medications on oral health. With over 15 million prescriptions written annually, GatorpH has the potential to significantly reduce the global burden of dental problems caused by medications like buprenorphine.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.